For muscle invasive bladder cancer, after neoadjuvant chemotherapy with cis/gem and surgery with residual tumor and lymph node involvement, would you consider adjuvant avelumab as an extrapolation base on the JAVELIN 100 results?  

https://meetinglibrary.asco.org/record/186872/abstract

How do you weigh the negative results from IMvigor 010 of adjuvant atezolizumab vs the results of JAVELIN 100 showing benefit of switch maintenance avelumab?   



Answer from: Medical Oncologist at Academic Institution

Answer from: Medical Oncologist at Academic Institution